---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-017562"
form_type: "8-K"
ticker: "PVCT"
cik: "0000315545"
company_name: "PROVECTUS BIOPHARMACEUTICALS, INC."
filed_at: "2022-06-23T23:59:59+00:00"
generated_at: "2026-06-24T23:45:29.111887+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Provectus shareholders approve reverse stock split, elect directors at annual meeting

## Summary
- All five director nominees elected: Bailey, Horowitz, Lacey, Pershing, Rodrigues; 102.4M broker non-votes.
- Advisory say-on-pay approved with 206.7M for vs 9.6M against.
- Ratification of Marcum LLP as auditor for 2022 passed with 313.4M for.
- Authorization to implement reverse stock split (1:10 to 1:50) approved with 300.5M for.
- Authorization to reduce authorized shares proportionally to reverse split ratio approved with 302.5M for.

## SEC filing metadata
- accession: 0001493152-22-017562
- form_type: 8-K
- ticker: PVCT
- cik: 0000315545
- company_name: PROVECTUS BIOPHARMACEUTICALS, INC.
- filed_at: 2022-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/315545/000149315222017562/0001493152-22-017562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/315545/000149315222017562/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-017562
- JSON: https://secwatch.observer/filing/0001493152-22-017562.json
- Plain text: https://secwatch.observer/filing/0001493152-22-017562.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.